高级检索
当前位置: 首页 > 详情页

Risk factor differences between type 2 diabetes patients with ischemic cerebrovascular versus coronary heart diseases at admission

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Neurology, The First People’s Hospital of Yunnan Province, Kunming 510032, China [2]Department of Neurology and Stroke Center, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510080, China
出处:
ISSN:

关键词: Type 2 diabetes mellitus Ischemic cerebrovascular diseases Coronary heart diseases Risk factors At admission

摘要:
Aims: Type 2 diabetes mellitus (T2DM) is a major risk factor, and shares many common risk factors with ischemic cerebrovascular diseases (ICVD) and coronary heart diseases (CHD). Few studies have directly compared the differences in common risk factors between T2DM patients with ICVD and CHD at admission. Methods: In this cross-sectional study, T2DM patients with or without first-ever ICVD or CHD admitted to our hospital over 3 years were enrolled. Patients' data were retrospectively collected and compared using multivariate logistic regression analyses. Results: In total, 1208 T2DM patients were enrolled (57.5% men). The median age was 59 years (interquartile range [IQR]51-69), and duration of diabetes was 7 years (IQR 3-10). Two hundred and two patients (16.7%) were diagnosed with ICVD, 345 (28.6%) with CHD, and 661 (54.7%) had neither ICVD nor CHD. Compared with T2DM patients without ICVD or CHD, ICVD and CHD patients had higher systolic blood pressure (SBP) and older age but lower high-density lipoprotein cholesterol levels (all p < 0.01), whereas reduced estimated glomerular filtration rate was only associated with CHD (p < 0.05). Furthermore, ICVD patients had higher SBP (every 10-mmHg increase, OR = 1.38, 95% CI: 1.26-1.51) and HbA1c levels (OR = 1.18, 95% Cl: 1.06-1.31) than CHD patients. Conclusions: T2DM patients with ICVD and CHD have differences in common risk factors at admission. Higher systolic blood pressure and HbA1c levels may indicate ICVD. (C) 2015 Elsevier Inc. All rights reserved.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2015]版:
大类 | 3 区 医学
小类 | 4 区 内分泌学与代谢
最新[2023]版:
大类 | 3 区 医学
小类 | 4 区 内分泌学与代谢
JCR分区:
出版当年[2014]版:
Q2 ENDOCRINOLOGY & METABOLISM
最新[2023]版:
Q3 ENDOCRINOLOGY & METABOLISM

影响因子: 最新[2023版] 最新五年平均 出版当年[2014版] 出版当年五年平均 出版前一年[2013版] 出版后一年[2015版]

第一作者:
第一作者机构: [1]Department of Neurology, The First People’s Hospital of Yunnan Province, Kunming 510032, China
共同第一作者:
通讯作者:
通讯机构: [2]Department of Neurology and Stroke Center, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510080, China [*1]Department of Neurology and Stroke Center, The First Affiliated Hospital, Sun Yat-Sen University, No.58 Zhongshan Road 2, Guangzhou 510080, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:82571 今日访问量:0 总访问量:681 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号